The role of vascular endothelial growth factor in peritoneal hyperpermeability during CAPD-related peritonitis.
Szeto
Cheuk-Chun
CC
Department of Medicine & Therapeutics, Prince of Wales Hospital, The Chinese University of Hong Kong, Shatin. ccszeto@cuhk.edu.hk
Wong
Teresa Yuk-Hwa
TY
Lai
Ka-Bik
KB
Chow
Kai-Ming
KM
Li
Philip Kam-Tao
PK
D002452:Cell Count; D015314:Dialysis Solutions / Q000737:chemistry; D016228:Endothelial Growth Factors / Q000032:analysis / Q000502:physiology*; D006801:Humans; D008222:Lymphokines / Q000032:analysis / Q000502:physiology*; D010531:Peritoneal Dialysis, Continuous Ambulatory / Q000009:adverse effects*; D010537:Peritoneum / Q000473:pathology / Q000503:physiopathology*; D010538:Peritonitis / Q000209:etiology / Q000503:physiopathology*; D010539:Permeability; D010865:Pilot Projects; D016212:Transforming Growth Factor beta / Q000032:analysis; D053773:Transforming Growth Factor beta1; D014409:Tumor Necrosis Factor-alpha / Q000032:analysis; D042461:Vascular Endothelial Growth Factor A; D042442:Vascular Endothelial Growth Factors
D015314:Dialysis Solutions; D016228:Endothelial Growth Factors; D008222:Lymphokines; C508960:TGFB1 protein, human; D016212:Transforming Growth Factor beta; D053773:Transforming Growth Factor beta1; D014409:Tumor Necrosis Factor-alpha; D042461:Vascular Endothelial Growth Factor A; D042442:Vascular Endothelial Growth Factors